RNA interference in biology and disease - PowerPoint PPT Presentation

1 / 18
About This Presentation
Title:

RNA interference in biology and disease

Description:

... was first characterized in the nematode worm Caenorhabditis elegans by Fire and colleagues. They found that double-stranded RNA (dsRNA) induced a sequence ... – PowerPoint PPT presentation

Number of Views:788
Avg rating:3.0/5.0
Slides: 19
Provided by: rnaWh
Category:

less

Transcript and Presenter's Notes

Title: RNA interference in biology and disease


1
RNA interference in biology and disease
  • Yang liu qing

2
Content Summarization
Introduction
Mechanisms
Application
Limitation
conclusion
3
Introduction
  • RNA interference (RNAi) was first characterized
    in the nematode worm Caenorhabditis elegans by
    Fire and colleagues.
  • They found that double-stranded RNA (dsRNA)
    induced a sequence-specific silencing response
    which is more efficient than customarily used
    single-stranded antisense RNA

4
  • .

back
5
  • ds RNA molecules can be recognized and cleaved
    into 21-23 nucleotide siRNAs by the
    RNaseIII-like enzyme termed Dicer.

Those siRNAs or synthetic siRNAs are incorporated
into the RNA-induced silencing complex (RISC)
RISC has helicase, exonuclease, endonuclease,
and homology-searching domains.
6
RNA interference in mammalian cells
  • Knock-out models in experiment systems have two
    significant disadvantages
  • First, it cannot be used for studying
    developmental or cell typespecific effects
  • Second, this method is both labor and time
    intensive
  • In theory, these problems could be resolved by
    delivering artificially synthesized siRNA
  • into mammal cells.

7
Stable RNA interference
  • But this effect is transient
  • How to make it stably work in the
  • experimental system ?

8
  • To address these issues, mammalian
  • expression vectors were designed to direct the
    intracellular
  • synthesis of siRNAs

back
9
Research Applications of RNAi
  • It can use for reverse genetic to identify a
    genes phenotype
  • It can combine with genomics to perform
    large-scale genetic screens aimed at gene
    discovery

10
Therapeutic Applications of RNAi
  • siRNAs can specifically target nucleic acid of
    the virus and the genes expression of cancer
    cell
  • The author use leukemia therapy as a example
    leukemia can be treated through silencing of a
    fusion protein, which is most important for such
    diseases pathology

back
11
Limitations of RNAi
  • Two main limitations of RNAi are
  • Nonspecific effects
  • off-target effects

12
Interferon induction by siRNAs
Directly or indirectly activate the transcription
of specific genes through IFN-independent pathways
dsRNA
2-5A binds and activates RNase L, resulting in
the nonspecific degradation of cellular
single-stranded RNA, and the onset of apoptosis
binds to constitutively expressed dsRNA
recognition proteins
directly mediate antiviral events
Inhibits protein synthesis
also present at basal levels to directly respond
to the initial infection
activation of NFkB and ATF2
Upregulation of IFNs
Phosphorylation of eIF2
Converts ATP to 2-5A
ISGs transcription
PKR and 2-5A synthetase
13
  • Nonspecific effects can also occur in response to
    siRNA. But these effects are concentration
    dependent
  • To design a highly efficient siRNA be used at
    lower concentrations, can reduce the
    concentration-dependent nonspecific side effects

14
  • Nonspecific effects can occur to a much higher
    degree in response to siRNAs synthesized from Pol
    IIIdriven promoters.
  • One study indicates that the 5 region of these
    enzymatically produced siRNAs contain elements
    that could be traced as responsible for ISG
    induction

15
Off-target effect
siRNA have a similar cellular machinery with
miRNA, for the loose homology requirements for
activation of miRNA function, siRNA can works as
a miRNA even in a low concentration
back
16
Conclusion
  • (1) using available information and algorithms to
    design the most effective and specific siRNA
    possible so that it can be used at very low
    concentrations
  • (2) using several siRNAs against the same target
    since it is unlikely that they all would have
    similar sequence-dependent off-target effects
  • (3) using different control siRNAs against
    measurable irrelevant genes
  • (4) rescuing the phenotype caused by an siRNA by
    ectopic expression of a version of the gene that
    cannot be silenced by the siRNA

17
  • Thank You!


18
Indirectly activation effect of dsRNA
back
Write a Comment
User Comments (0)
About PowerShow.com